Reaction
Uterine Haemorrhage reporting signals
As of the last recalculation, Uterine Haemorrhage appears in 4,204 FAERS reports alongside 35 co-occurring drug terms. The strongest observed disproportionality signal is MISOPROSTOL (PRR 38.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Misoprostol | 74 | 38.3 | 38.6 |
| Etonogestrel | 297 | 33.1 | 33.3 |
| Levonorgestrel | 651 | 18.8 | 18.8 |
| Tranexamic Acid | 27 | 15.1 | 15.2 |
| Progesterone | 52 | 11.4 | 11.4 |
| Rivaroxaban | 404 | 10.5 | 10.5 |
| Medroxyprogesterone Acetate | 103 | 10.5 | 10.5 |
| Copper | 81 | 9.5 | 9.5 |
| Naltrexone Hydrochloride And Bupropion Hydrochloride | 15 | 8.7 | 8.8 |
| Etonogestrel And Ethinyl Estradiol | 32 | 7.2 | 7.2 |
| Conjugated Estrogens And Medroxyprogesterone Acetate | 29 | 6.1 | 6.1 |
| Raloxifene Hydrochloride | 15 | 5.1 | 5.1 |
| Estradiol | 85 | 5.0 | 5.0 |
| Fondaparinux Sodium | 8 | 4.9 | 4.9 |
| Estradiol Gel 0.1% | 41 | 4.5 | 4.5 |
| Estradiol Transdermal | 41 | 4.5 | 4.5 |
| Drospirenone And Ethinyl Estradiol | 40 | 4.5 | 4.5 |
| Leuprolide Acetate | 67 | 4.3 | 4.3 |
| Iron | 55 | 4.1 | 4.1 |
| Ferrous Sulfate | 39 | 3.9 | 3.9 |
| Lapatinib | 12 | 3.8 | 3.8 |
| Estrogens, Conjugated | 44 | 3.7 | 3.7 |
| Conjugated Estrogens | 43 | 3.7 | 3.7 |
| Oxymorphone Hydrochloride | 7 | 3.0 | 3.0 |
| Inclisiran | 4 | 2.5 | 2.5 |
| Prasugrel Hydrochloride | 5 | 2.4 | 2.4 |
| Interferon Beta-1A | 85 | 2.2 | 2.2 |
| Macitentan | 29 | 2.1 | 2.1 |
| Eltrombopag Olamine | 9 | 1.9 | 1.9 |
| Sodium Oxybate | 24 | 1.8 | 1.8 |
| Dabigatran Etexilate | 27 | 1.7 | 1.7 |
| Dabigatran Etexilate Mesylate | 23 | 1.6 | 1.6 |
| Brexpiprazole | 5 | 1.5 | 1.5 |
| Relugolix | 7 | 1.5 | 1.5 |
| Natalizumab | 40 | 1.1 | 1.1 |